Skip to main content
. 2020 Dec 8;11:598939. doi: 10.3389/fphar.2020.598939

TABLE 1.

Primary antibodies used in this study.

Antibody Description Application Source
TLR4 Transmembrane receptor WB, IHC Santa cruz
MyD88 Myeloid differentiation protein WB Santa cruz
p-NF-κB p65 Activated transcription factor WB Santa cruz
NF-κB p65 Transcription factor WB, IHC Santa cruz
p-IκBα Activated inhibitory protein of NF-κB WB Cell signaling technology
IκBα Inhibitory protein of NF-κB WB Cell signaling technology
p-IKKα/β Activated IκB kinase WB Cell signaling technology
IKKα IκB kinase WB Cell signaling technology
IKKβ IκB kinase WB Cell signaling technology
Procaspase-3 Precursor form of caspase-3 WB Abcam
cleaved caspase-3 Active form of caspase-3 WB Abcam
PARP Cleavage targets of caspase-3 WB Abcam
Cleaved PARP Cleavage of PARP WB Abcam
E-cadherin Intercellular junction protein WB Abcam
Vimentin Cytoskeletal protein WB Abcam
β-actin Cytoskeletal protein WB Boster

WB, Western blot; IHC, Immunohistochemistry.